| |
| |
|
|
R E S O L U T I O N
|
|
|
WHEREAS, The observance of Premenstrual Dysphoric Disorder |
|
|
Awareness Day on November 8, 2025, provides a fitting opportunity |
|
|
to rally support for women living with the condition; and |
|
|
WHEREAS, Premenstrual Dysphoric Disorder is a cyclical |
|
|
hormone-based mood disorder with mental, emotional, and physical |
|
|
symptoms that arise each month during the premenstrual phase of the |
|
|
menstrual cycle; PMDD presents itself one to two weeks before an |
|
|
individual begins menstruating, and symptoms may include mood |
|
|
swings, irritability, depression, difficulty focusing, sensitivity |
|
|
to rejection, changes in appetite, and muscle pain; typically, the |
|
|
disorder is diagnosed by tracking symptoms on a daily basis for two |
|
|
or more menstrual cycles; and |
|
|
WHEREAS, PMDD symptoms can significantly disrupt daily life |
|
|
and exacerbate mental health issues; many women with PMDD report |
|
|
experiencing suicidal thoughts during symptomatic times, and the |
|
|
disorder has led to higher rates of attempted suicide and |
|
|
self-harm; individuals experiencing the disorder may suffer from |
|
|
frequently missed workdays, reduced productivity, strained |
|
|
relationships, career disruption, educational setbacks, and |
|
|
financial stress from ongoing health care needs; and |
|
|
WHEREAS, An estimated 115 million women around the globe are |
|
|
affected by PMDD; like most menstrual disorders, PMDD diagnoses are |
|
|
very rare and research on the disorder is extremely limited; |
|
|
although PMDD affects up to five percent of women of childbearing |
|
|
age in the United States, over half of people with the disorder |
|
|
experience misdiagnoses or dismissals from providers; due to stigma |
|
|
surrounding mental health and menstruation, people with PMDD often |
|
|
suffer in silence and delay care, which increases the risk of |
|
|
negative outcomes; currently, there are no cures for the disorder, |
|
|
and it is most commonly managed by the prescription of oral |
|
|
contraceptives and antidepressant medications as well as through |
|
|
lifestyle choices; and |
|
|
WHEREAS, PMDD is a serious and life-changing health issue, |
|
|
and the observance of Premenstrual Dysphoric Disorder Awareness Day |
|
|
serves as a means of educating the public and promoting further |
|
|
research on menstrual and hormone-related mood disorders; now, |
|
|
therefore, be it |
|
|
RESOLVED, That the House of Representatives of the 89th Texas |
|
|
Legislature hereby recognize November 8, 2025, as Premenstrual |
|
|
Dysphoric Disorder Awareness Day and encourage all Texans to learn |
|
|
more about PMDD. |
| |
|
|
Howard |
|
|
|
|
|
______________________________ |
|
|
Speaker of the House |
| |
|
|
I certify that H.R. No. 1298 was adopted by the House on May |
|
|
29, 2025, by a non-record vote. |
|
|
|
|
|
______________________________ |
|
|
Chief Clerk of the House |
| |